The prize is an oral spleen tyrosine kinase (SYK) inhibitor, called cevidoplenib, which has been developed by Korea’s Oscotec ...
What Is Doptelet, and Why Does It Matter? Doptelet (avatrombopag) is a prescription medicine that helps the body make more platelets (cells that help stop bleeding). First approved in 2018 for adults, ...
Early detection and innovative therapies are crucial for managing rare blood disorders like VITT, ITP, and hemophilia. Marstacimab's approval offers a new subcutaneous treatment option for hemophilia ...
How Does It Work for ITP? There is no cure for ITP. Its symptoms can vary from person to person, with some people not having any symptoms. Because ITP causes low platelets, the main side effects that ...
While Sanofi originally had its eye on tolebrutinib when it purchased its partner Principia Biopharma for $3.7 billion five years ago, another one of the Bruton tyrosine kinase (BTK) inhibitors ...
It was the day before Halloween. Wood River mom Allison Schardan was caring for her two children when she noticed her oldest, Carsen, 3, was covered in bruises and small red dots. Immediately, she ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results